Journal article
Low Molecular Weight Heparin and Unfractionated Heparin in the Early Pharmacologic Management of Acute Coronary Syndromes: A Meta-analysis of Randomized Clinical Trials
Abstract
Background: The standard of care in Acute Coronary Syndromes (ACS) includes a full complement of antischemic and antithrombotic therapy. Although aspirin is used widely and concomitant anticoagulation is recommended, the comparative benefits of low molecular weight heparin (LMWH) and unfractionated heparin (UFH) have not been defined.Methods/Results: A meta-analysis including all randomized clinical trials comparing LMWH and UFH for the …
Authors
Le Nguyen M-T; Spencer FA
Journal
Journal of Thrombosis and Thrombolysis, Vol. 12, No. 3, pp. 289–295
Publisher
Springer Nature
Publication Date
December 2001
DOI
10.1023/a:1015287311065
ISSN
0929-5305